徐亦迅，赛诺菲制药公司转化研究部计算生物学总监。博士毕业于美国霍普金斯大学医学院，先后就职于五家生物制药公司。他曾在美国默克制药公司的系统毒理学组负责代谢组学和转录组学数据的整合，在代谢组学应用于小分子药物的安全性测试上取得了进展。之后曾在Infinity公司从事直接与抗癌药临床试验有关的生物信息学项目。2016年加入赛诺菲以来，一直专注于各类组学数据与遗传学数据的整合，对多个自身免疫病和罕见病新药研发项目做出了贡献。

Dr. Ethan Xu is currently Director of Bioinformatics at the Translational Sciences Unit of Sanofi Genzyme. Ethan obtained his Ph.D. in Biochemistry, Cellular and Molecular Biology from Johns Hopkins University School of Medicine. While working in the Systems Toxicology Group of Merck Research Laboratories, Ethan developed a new method to integrate metabolomics with transcriptomics data to build detailed models of drug-induced toxicity. At the biotech company Infinity Pharmaceuticals, Ethan built a cloud-based clinical NGS pipeline and data warehouse to support multiple oncology clinical trials and translational biomarker discovery. At Sanofi US, Ethan has been leading Translational Sciences’ data science efforts to integrate human genetics with multi-omics profiling for the therapeutic pipeline development in autoimmune diseases and rare diseases.